Research ArticleArticle
Pharmacokinetics and Catabolism of [3H]TAK-164, a Guanylyl Cyclase C Targeted Antibody-Drug Conjugate
Jayaprakasam Bolleddula, Abhi Shah, Mohammad Shadid, Afrand Kamali, Michael D. Smith and Swapan K. Chowdhury
Drug Metabolism and Disposition November 2020, 48 (11) 1239-1245; DOI: https://doi.org/10.1124/dmd.120.000194
Jayaprakasam Bolleddula
Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts
Abhi Shah
Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts
Mohammad Shadid
Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts
Afrand Kamali
Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts
Michael D. Smith
Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts
Swapan K. Chowdhury
Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Pharmacokinetics and Catabolism of Radiolabeled TAK-164
Jayaprakasam Bolleddula, Abhi Shah, Mohammad Shadid, Afrand Kamali, Michael D. Smith and Swapan K. Chowdhury
Drug Metabolism and Disposition November 1, 2020, 48 (11) 1239-1245; DOI: https://doi.org/10.1124/dmd.120.000194
Research ArticleArticle
Pharmacokinetics and Catabolism of Radiolabeled TAK-164
Jayaprakasam Bolleddula, Abhi Shah, Mohammad Shadid, Afrand Kamali, Michael D. Smith and Swapan K. Chowdhury
Drug Metabolism and Disposition November 1, 2020, 48 (11) 1239-1245; DOI: https://doi.org/10.1124/dmd.120.000194
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement